Bristol-Myers Squibb Company

Organization

New York, NY, US

Ticker Symbols

NYSE:BMY

PHARMACEUTICAL PREPARATIONS
Business Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
Mailing Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
State Location
NY
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Substituted thienopyrroles as PAD4 inhibitors
- Patent number 11,981,680
- Issue date May 14, 2024
- Bristol-Myers Squibb Company
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding antibodies which bind natural kille...
- Patent number 11,981,734
- Issue date May 14, 2024
- Bristol-Myers Squibb Company
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Patent number 11,970,511
- Issue date Apr 30, 2024
- Bristol-Myers Squibb Company
- Richard A. Hartz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted bicyclic compounds useful as T cell activators
- Patent number 11,964,973
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Robert G. Gentles
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
- Patent number RE49931
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Alaric J. Dyckman
Information Patent Grant
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in...
- Patent number 11,965,031
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Vladimir Coric
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies against CD3EPSILON and ROR1
- Patent number 11,952,421
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD40 antibodies and uses thereof
- Patent number 11,952,427
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acids encoding anti-TREM-1 antibodies
- Patent number 11,952,420
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Achal Pashine
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunomodulators
- Patent number 11,952,434
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Kevin W. Gillman
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Cyclic dinucleotides as anticancer agents
- Patent number 11,945,834
- Issue date Apr 2, 2024
- Bristol-Myers Squibb Company
- Brian E. Fink
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Devices and systems for delivery of combination therapies
- Patent number 11,944,588
- Issue date Apr 2, 2024
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
- Patent number RE49893
- Issue date Apr 2, 2024
- Bristol-Myers Squibb Company
- Alaric J. Dyckman
Information Patent Grant
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
- Patent number RE49880
- Issue date Mar 26, 2024
- Bristol-Myers Squibb Company
- Alaric J. Dyckman
Information Patent Grant
Tricyclic heteroaryl-substituted quinoline and azaquinoline compoun...
- Patent number 11,932,658
- Issue date Mar 19, 2024
- Bristol-Myers Squibb Company
- Xiaojun Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonistic CD40 monoclonal antibodies and uses thereof
- Patent number 11,926,673
- Issue date Mar 12, 2024
- Bristol-Myers Squibb Company
- Aaron Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TREM-1 antibodies and uses thereof
- Patent number 11,919,954
- Issue date Mar 5, 2024
- Bristol-Myers Squibb Company
- Achal Pashine
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating tumor
- Patent number 11,919,957
- Issue date Mar 5, 2024
- Bristol-Myers Squibb Company
- Prabhu Seshaiyer Bhagavatheeswaran
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies against IL-7R alpha subunit and uses thereof
- Patent number 11,919,962
- Issue date Mar 5, 2024
- Bristol-Myers Squibb Company
- Aaron Paul Yamniuk
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted quinolinylcyclohexylpropanamide compounds and improved...
- Patent number 11,919,863
- Issue date Mar 5, 2024
- Bristol-Myers Squibb Company
- Albert J. Delmonte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6-azaindole compounds
- Patent number 11,912,703
- Issue date Feb 27, 2024
- Bristol-Myers Squibb Company
- Alaric J. Dyckman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating systemic lupus erythematosus using a domain ant...
- Patent number 11,912,769
- Issue date Feb 27, 2024
- Bristol-Myers Squibb Company
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified self-immolating moieties for use in prodrugs and conjugate...
- Patent number 11,911,483
- Issue date Feb 27, 2024
- Bristol-Myers Squibb Company
- Yam B. Poudel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the selection of binding proteins
- Patent number 11,913,137
- Issue date Feb 27, 2024
- Bristol-Myers Squibb Company
- Dasa Lipovsek
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Predictive peripheral blood biomarker for checkpoint inhibitors
- Patent number 11,899,017
- Issue date Feb 13, 2024
- Bristol-Myers Squibb Company
- Nataly Manjarrez Orduño
- G01 - MEASURING TESTING
Information Patent Grant
Apixaban formulations
- Patent number 11,896,586
- Issue date Feb 13, 2024
- Bristol-Myers Squibb Company
- Sherif Ibrahim Farag Badawy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted heterocyclic compounds
- Patent number 11,884,650
- Issue date Jan 30, 2024
- Bristol-Myers Squibb Company
- Steven H. Spergel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-substituted propionic acids as αV integrin inhibitors
- Patent number 11,884,661
- Issue date Jan 30, 2024
- Bristol-Myers Squibb Company
- Guohua Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted indole compounds useful as TLR inhibitors
- Patent number 11,878,975
- Issue date Jan 23, 2024
- Bristol-Myers Squibb Company
- Alaric J. Dyckman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic compounds
- Patent number 11,866,414
- Issue date Jan 9, 2024
- Bristol-Myers Squibb Company
- Steven H. Spergel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Anti-LAG-3 Antibodies to Treat Hematological Malignancies
- Publication number 20240150459
- Publication date May 9, 2024
- Bristol-Myers Squibb Company
- Andres A. GUTIERREZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS
- Publication number 20240141059
- Publication date May 2, 2024
- Bristol-Mayers Squibb Company
- Nils LONBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-...
- Publication number 20240132608
- Publication date Apr 25, 2024
- Bristol-Myers Squibb Company
- Josephine M. CARDARELLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Binding to Human PAD4 and Uses Thereof
- Publication number 20240132622
- Publication date Apr 25, 2024
- Bristol-Myers Squibb Company
- Lin Hui Su
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS
- Publication number 20240124489
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Sreekantha Ratna Kumar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS
- Publication number 20240122857
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Jing TAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING LIVER DISEASES
- Publication number 20240123031
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Edgar Davidson CHARLES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
- Publication number 20240124592
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Demetrios MANEKAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antagonistic CD40 Monoclonal Antibodies and Uses Thereof
- Publication number 20240124597
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Aaron YAMNIUK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS USEFUL AS IMMUNOMODULATORS
- Publication number 20240124417
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Kap-Sun YEUNG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PATIENT RESPONSE-BASED BIOMARKER TOPOLOGY QUANTIFICATION AND ASSESS...
- Publication number 20240127451
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- George C. LEE
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20240124421
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Steven H. Spergel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY
- Publication number 20240124589
- Publication date Apr 18, 2024
- Bristol-Myers Squibb Company
- Marina TSCHAIKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ROR1 MACROCYCLIC PEPTIDES AND COMPOSITIONS
- Publication number 20240116988
- Publication date Apr 11, 2024
- Bristol-Myers Squibb Company
- JENNIFER X. QIAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS
- Publication number 20240117044
- Publication date Apr 11, 2024
- Bristol-Myers Squibb Company
- Anke KLIPPEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaryl Compounds as Ligand Directed Degraders of IRAK4
- Publication number 20240109881
- Publication date Apr 4, 2024
- Bristol-Myers Squibb Company
- Timothy Rasmusson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
- Publication number 20240109888
- Publication date Apr 4, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOFURAN COMPOUNDS AS STING AGONISTS
- Publication number 20240109899
- Publication date Apr 4, 2024
- Bristol-Myers Squibb Company
- BRIAN E. FINK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER
- Publication number 20240101666
- Publication date Mar 28, 2024
- Bristol-Myers Squibb Company
- Laurence David TOMS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT AND DETECTION METHODS FOR INFLAMMATORY BOWEL DISEASE
- Publication number 20240103008
- Publication date Mar 28, 2024
- Bristol-Myers Squibb Company
- Frederic Baribaud
- G01 - MEASURING TESTING
Information Patent Application
AUTOMATED PARALLEL AUTOSAMPLER SYSTEM AND METHOD FOR DRAWING CHROMA...
- Publication number 20240102973
- Publication date Mar 28, 2024
- Bristol-Myers Squibb Company
- Cristopher Hollander
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Binding to VISTA at Acidic pH
- Publication number 20240092907
- Publication date Mar 21, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF LAG-3 POSITIVE TUMORS
- Publication number 20240092911
- Publication date Mar 21, 2024
- Bristol-Myers Squibb Company
- James NOVOTNY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND...
- Publication number 20240091354
- Publication date Mar 21, 2024
- Bristol-Myers Squibb Company
- Vikram SADINENI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUPRAMOLECULAR FILAMENTOUS ASSEMBLIES FOR PROTEIN PURIFICATION
- Publication number 20240082816
- Publication date Mar 14, 2024
- The Johns Hopkins University
- Honggang Cui
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANT...
- Publication number 20240076373
- Publication date Mar 7, 2024
- COMPUGEN LTD.
- Inbal BARBIRO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIGAND BINDING ASSAY USING MODIFIED RETINOL BINDING PROTEIN
- Publication number 20240077505
- Publication date Mar 7, 2024
- Bristol-Myers Squibb Company
- Ya FU
- G01 - MEASURING TESTING
Information Patent Application
SUBSTITUTED CARBAZOLE COMPOUNDS
- Publication number 20240076280
- Publication date Mar 7, 2024
- Bristol-Myers Squibb Company
- Dharmpal S. Dodd
- C07 - ORGANIC CHEMISTRY
Information Patent Application
WEE1 Degrading Compounds and Uses Thereof
- Publication number 20240067632
- Publication date Feb 29, 2024
- Bristol-Myers Squibb Company
- John Sapienza
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANT...
- Publication number 20240066123
- Publication date Feb 29, 2024
- Bristol-Myers Squibb Company
- Lori S. BURTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98472315 - LAGIMMU
- Serial number 98472315
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472299 - DURELIMMU
- Serial number 98472299
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472311 - DURLAGNIV
- Serial number 98472311
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472326 - BAMBROVA
- Serial number 98472326
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472301 - LAGDURITY
- Serial number 98472301
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472317 - NIVRELZA
- Serial number 98472317
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472305 - RELOPDUO
- Serial number 98472305
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472298 - DUALAGO
- Serial number 98472298
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472309 - ZAVLAG
- Serial number 98472309
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472325 - ORBRODA
- Serial number 98472325
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472320 - LAGLOTOK
- Serial number 98472320
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472321 - LAGOPDI
- Serial number 98472321
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98423625 - LIVE THE FUTURE
- Serial number 98423625
- Filing date Feb 27, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350774 - AZURAJAY
- Serial number 98350774
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350786 - ALNEBEAMM
- Serial number 98350786
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350769 - EZOJAY
- Serial number 98350769
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350788 - ALNEBEAM
- Serial number 98350788
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350777 - ULBEAMSA
- Serial number 98350777
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350778 - BINLUBEAM
- Serial number 98350778
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350780 - EZOBEAMA
- Serial number 98350780
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350784 - BONLUJAY
- Serial number 98350784
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98350981 - GOLSEEK
- Serial number 98350981
- Filing date Jan 10, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98303472 - MARKETING QUOTIENT
- Serial number 98303472
- Filing date Dec 7, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 35 - Advertising
Information Trademark
98292716 - NAVIJAY
- Serial number 98292716
- Filing date Nov 30, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98290534 - ALUJOULE
- Serial number 98290534
- Filing date Nov 29, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98290540 - BEAMIJAY
- Serial number 98290540
- Filing date Nov 29, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98290551 - JAYSYMBI
- Serial number 98290551
- Filing date Nov 29, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98290537 - AMZIJAY
- Serial number 98290537
- Filing date Nov 29, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98290542 - BEEMIJAY
- Serial number 98290542
- Filing date Nov 29, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98290543 - BEMFARZO
- Serial number 98290543
- Filing date Nov 29, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 1

Research Projects

Information Research Project
NEW FERMENTATION ANTINEOPLASTIC DRUG
- Application id 3610876

Bristol-Myers Squibb Company

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Substituted thienopyrroles as PAD4 inhibitors

Nucleic acid molecules encoding antibodies which bind natural kille...

Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors

Substituted bicyclic compounds useful as T cell activators

[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds

Use of anti-PD-1 antibody in combination with anti-CD27 antibody in...

Bispecific antibodies against CD3EPSILON and ROR1

Anti-CD40 antibodies and uses thereof

Nucleic acids encoding anti-TREM-1 antibodies

Immunomodulators

Cyclic dinucleotides as anticancer agents

Devices and systems for delivery of combination therapies

[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds

[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds

Tricyclic heteroaryl-substituted quinoline and azaquinoline compoun...

Antagonistic CD40 monoclonal antibodies and uses thereof

Anti-TREM-1 antibodies and uses thereof

Methods of treating tumor

Antibodies against IL-7R alpha subunit and uses thereof

Substituted quinolinylcyclohexylpropanamide compounds and improved...

6-azaindole compounds

Methods of treating systemic lupus erythematosus using a domain ant...

Modified self-immolating moieties for use in prodrugs and conjugate...

Methods for the selection of binding proteins

Predictive peripheral blood biomarker for checkpoint inhibitors

Apixaban formulations

Substituted heterocyclic compounds

3-substituted propionic acids as αV integrin inhibitors

Substituted indole compounds useful as TLR inhibitors

Substituted heterocyclic compounds

Patents Applicationslast 30 patents

Anti-LAG-3 Antibodies to Treat Hematological Malignancies

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY AND AN ANTI-...

Antibodies Binding to Human PAD4 and Uses Thereof

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS

PHARMACEUTICAL FORMULATIONS OF INDOLEAMINE 2, 3-DIOXYGENASE INHIBITORS

METHODS OF TREATING LIVER DISEASES

METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

COMPOUNDS USEFUL AS IMMUNOMODULATORS

PATIENT RESPONSE-BASED BIOMARKER TOPOLOGY QUANTIFICATION AND ASSESS...

SUBSTITUTED HETEROCYCLIC COMPOUNDS

METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY

ANTI-ROR1 MACROCYCLIC PEPTIDES AND COMPOSITIONS

TIM-3 ANTAGONISTS FOR THE TREATMENT AND DIAGNOSIS OF CANCERS

Heteroaryl Compounds as Ligand Directed Degraders of IRAK4

TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS

BENZOFURAN COMPOUNDS AS STING AGONISTS

LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER

TREATMENT AND DETECTION METHODS FOR INFLAMMATORY BOWEL DISEASE

AUTOMATED PARALLEL AUTOSAMPLER SYSTEM AND METHOD FOR DRAWING CHROMA...

Antibodies Binding to VISTA at Acidic pH

TREATMENT OF LAG-3 POSITIVE TUMORS

COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND...

SUPRAMOLECULAR FILAMENTOUS ASSEMBLIES FOR PROTEIN PURIFICATION

COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANT...

LIGAND BINDING ASSAY USING MODIFIED RETINOL BINDING PROTEIN

SUBSTITUTED CARBAZOLE COMPOUNDS

WEE1 Degrading Compounds and Uses Thereof

COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANT...

Trademarklast 30 trademarks

98472315 - LAGIMMU

98472299 - DURELIMMU

98472311 - DURLAGNIV

98472326 - BAMBROVA

98472301 - LAGDURITY

98472317 - NIVRELZA

98472305 - RELOPDUO

98472298 - DUALAGO

98472309 - ZAVLAG

98472325 - ORBRODA